Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • vTv Therapeutics amends IPO

    vTv Therapeutics Inc., High Point, N.C. Business: Neurology, Endocrine/Metabolic, Inflammation Date announced: 2015-07-20 Type: IPO To be raised: Up to $132.8 million Shares: 7.8 million Price: $15-$17 Underwriters: …

    Published on 7/27/2015
  • Zynerba amends IPO

    Zynerba Pharmaceuticals Inc., Radnor, Pa. Business: Autoimmune, Neurology, Drug delivery Date announced: 2015-07-23 Type: IPO To be raised: Up to $45 million Shares: 3 million Price: $13-$15 Underwriters: Jefferies; …

    Published on 7/27/2015
  • Blue Earth Diagnostics completes venture financing

    Blue Earth Diagnostics Ltd., London, U.K. Business: Diagnostic Date completed: 2015-07-23 Type: Venture financing Raised: L18 million ($28.1 million) Investor: Syncona Partners LLP

    Published on 7/27/2015
  • Cevec completes venture financing

    Cevec Pharmaceuticals GmbH, Cologne, Germany Business: Supply/Service, Biomanufacturing Date completed: 2015-07-22 Type: Venture financing Raised: EUR4.5 million ($4.9 million) Investors: Investtodate; Peppermint …

    Published on 7/27/2015
  • CytRx completes follow-on

    CytRx Corp. (NASDAQ:CYTR), Los Angeles, Calif. Business: Cancer Date completed: 2015-07-21 Type: Follow-on Raised: $25.1 million Shares: 9.1 million Price: $2.75 Shares after offering: 64.8 million Underwriters: …

    Published on 7/27/2015
  • Dauntless Pharmaceuticals completes venture financing

    Dauntless Pharmaceuticals Inc., San Diego, Calif. Business: Cancer Date completed: 2015-07-21 Type: Venture financing Raised: $12 million Investor: Sofinnova Ventures

    Published on 7/27/2015
  • Dynavax completes follow-on

    Dynavax Technologies Corp. (NASDAQ:DVAX), Berkeley, Calif. Business: Inflammation, Infectious, Autoimmune Date completed: 2015-07-22 Type: Follow-on Raised: $125 million Shares: 4.5 million Price: $27.50 Shares after …

    Published on 7/27/2015
  • Exact Sciences completes follow-on

    Exact Sciences Corp. (NASDAQ:EXAS), Madison, Wis. Business: Diagnostic Date completed: 2015-07-21 Type: Follow-on Raised: $178.5 million Shares: 7 million Price: $25.50 Shares after offering: 95.9 million Underwriters: …

    Published on 7/27/2015
  • Exelixis completes follow-on

    Exelixis Inc. (NASDAQ:EXEL), South San Francisco, Calif. Business: Cancer Date completed: 2015-07-23 Type: Follow-on Raised: $135 million Shares: 25 million Price: $5.40 Shares after offering: 221 million Underwriters: …

    Published on 7/27/2015
  • Fibrocell completes follow-on

    Fibrocell Science Inc. (NASDAQ:FCSC), Exton, Pa. Business: Gene/Cell therapy Date completed: 2015-07-22 Type: Follow-on Raised: $15 million Shares: 2.6 million Price: $5.80 Shares after offering: 43.5 million …

    Published on 7/27/2015
  • GenSight Biologics completes venture financing

    GenSight Biologics S.A., Paris, France Business: Ophthalmic Date completed: 2015-07-23 Type: Venture financing Raised: $36 million Placement agent: Leerink Partners Investors: Fidelity; Jennison Associates; Sphera …

    Published on 7/27/2015
  • KalVista completes venture financing

    KalVista Pharmaceuticals Ltd., Salisbury, U.K. Business: Ophthalmic Date completed: 2015-07-22 Type: Venture financing Raised: $33 million Investors: Novo A/S; SV Life Sciences; RA Capital Management; Longwood Fund; …

    Published on 7/27/2015
  • Leukocare completes venture financing

    Leukocare AG, Martinsried, Germany Business: Supply/Service Date completed: 2015-07-22 Type: Venture financing Raised: Not disclosed Investors: LifeCare Partners; new investors; and an undisclosed investor Note: The …

    Published on 7/27/2015
  • MedGenome completes venture financing

    MedGenome Inc., San Francisco, Calif. Business: Diagnostic, Genomics Date completed: 2015-07-22 Type: Venture financing Raised: $20 million Investor: Sequoia Capital

    Published on 7/27/2015
  • Memo Therapeutics completes venture financing

    Memo Therapeutics AG, Basel, Switzerland Business: Antibodies, Supply/Service Date completed: 2015-07-22 Type: Venture financing Raised: CHF2.3 million ($2.4 million) Investors: Redalpine Venture Partners; Zuercher …

    Published on 7/27/2015
  • Motif Bio completes placing

    Motif Bio plc (LSE:MTFB), London, U.K. Business: Infectious Date completed: 2015-07-22 Type: Placing Raised: L22 million ($34.3 million) Shares: 44 million Price: 50p Shares after offering: 108.3 million Placement …

    Published on 7/27/2015
  • Neos Therapeutics completes IPO

    Neos Therapeutics Inc. (NASDAQ:NEOS), Grand Prairie, Texas Business: Drug delivery, Neurology Date completed: 2015-07-23 Type: IPO Raised: $72 million Shares: 4.8 million Price: $15 Shares after offering: 14.5 million …

    Published on 7/27/2015
  • Novacyt completes bond

    Novacyt S.A. (Euronext:ALNOV), Velizy-Villacoublay, France Business: Supply/Service Date completed: 2015-07-20 Type: Bond Raised: EUR3.5 million ($3.8 million) Investor: Kreos Capital Note: The three-year bonds bear 12.…

    Published on 7/27/2015
  • Novacyt completes private placement

    Novacyt S.A. (Euronext:ALNOV), Velizy-Villacoublay, France Business: Supply/Service Date completed: 2015-07-23 Type: Private placement Raised: EUR2 million ($2.2 million) Shares: 399,500 Price: EUR5 Shares after …

    Published on 7/27/2015
  • Oxford Nanopore completes venture financing

    Oxford Nanopore Technologies Ltd., Oxford, U.K. Business: Supply/Service Date completed: 2015-07-21 Type: Venture financing Raised: L70 million ($109.2 million) Investors: New investors; existing investors

    Published on 7/27/2015
  • Pharming completes debt financing

    Pharming Group N.V. (Euronext:PHARM), Leiden, the Netherlands Business: Cardiovascular, Hematology, Biomanufacturing Date completed: 2015-07-20 Type: Debt financing Raised: EUR15.6 million ($16.9 million) Investors: …

    Published on 7/27/2015
  • Ra Pharmaceuticals completes venture financing

    Ra Pharmaceuticals Inc., Cambridge, Mass. Business: Cancer, Infectious Date completed: 2015-07-23 Type: Venture financing Raised: $58.5 million Investors: RA Capital Management; Novo Ventures; Lightstone Ventures; Rock …

    Published on 7/27/2015
  • Radius Health completes follow-on

    Radius Health Inc. (NASDAQ:RDUS), Cambridge, Mass. Business: Musculoskeletal, Endocrine/Metabolic, Cancer Date completed: 2015-07-22 Type: Follow-on Raised: $300 million Shares: 4.1 million Price: $74 Shares after …

    Published on 7/27/2015
  • RaNATherapeutics completes venture financing

    RaNA Therapeutics Inc., Cambridge, Mass. Business: Gene/Cell therapy, Neurology, Musculoskeletal Date completed: 2015-07-23 Type: Venture financing Raised: $55 million Investors: Merck Research Labs Venture Fund; The …

    Published on 7/27/2015
  • Resverlogix completes private placement of units

    Resverlogix Corp. (TSX:RVX), Calgary, Alberta Business: Cardiovascular, Neurology, Endocrine/Metabolic Date completed: 2015-07-21 Type: Private placement of units Raised: C$50.4 million ($38.9 million) Units: 18.9 …

    Published on 7/27/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993